Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Prepaid Assets (2022 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Prepaid Assets for 4 consecutive years, with $1.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Prepaid Assets rose 19.8% to $1.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.5 million, a 19.8% increase, with the full-year FY2024 number at $2.1 million, up 64.36% from a year prior.
  • Prepaid Assets was $1.5 million for Q3 2025 at Orchestra BioMed Holdings, down from $1.7 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $2.3 million in Q1 2023 to a low of $36417.0 in Q2 2022.
  • A 4-year average of $1.2 million and a median of $1.3 million in 2023 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: soared 3931.08% in 2023, then plummeted 48.31% in 2024.
  • Orchestra BioMed Holdings' Prepaid Assets stood at $533000.0 in 2022, then skyrocketed by 139.02% to $1.3 million in 2023, then skyrocketed by 64.36% to $2.1 million in 2024, then decreased by 26.89% to $1.5 million in 2025.
  • Per Business Quant, the three most recent readings for OBIO's Prepaid Assets are $1.5 million (Q3 2025), $1.7 million (Q2 2025), and $1.8 million (Q1 2025).